Investors
The Investment Case for GuideAI Health
GuideAI Health is building the first AI platform for early detection of PAD—addressing a $200B+ problem with a proven path to clinical adoption and commercial scale.
- July 10, 2026 GuideAI Health Announces Marketing and Communications Programs
- July 6, 2026 GuideAI Health Appoints Renowned Interventional Radiologist Dr. James Benenati to Advisory Board Following FDA 510(k) Clearance of VAOT
- July 2, 2026 GuideAI Health Corp. Engages Market Maker
- June 29, 2026 GuideAI Health Corp. to Begin Trading on Cboe Canada Under the Symbol "GDAI"
- June 22, 2026 GuideAI Health Receives FDA 510(k) Clearance for VascularAssist Occlusion Triage
- June 16, 2026 GuideAI Health Corp. Announces Closing of Business Combination, Subscription Receipt Offering, and Filing of Final Prospectus